NCT02069041 2018-11-21A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver CancerEli Lilly and CompanyPhase 1 Completed8 enrolled 16 charts
NCT00599924 2015-07-15Study Of Sunitinib Plus FOLFOX In Patients With Solid TumorsPfizerPhase 1 Completed53 enrolled 31 charts